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Abstract
Background: Mitral stenosis (MS) is still the most common complication of acute rheumatic 
fever in Turkey. Rheumatic carditis affects not only cardiac valves but also myocardium. In 
this study, we aimed to evaluate the subclinical left ventricular (LV) systolic dysfunction and 
contraction of short and long axial circumferential and longitudinal fibers by pulsed wave 
tissue Doppler in rheumatic MS patients who have preserved LV systolic function in 2D echo-
cardiography.
Methods: Fifteen severe, 20 moderate rheumatic MS patients hospitalized for mitral balloon 
valvuloplasty, and 15 patients who had normal echocardiographic findings were included in the 
study. After routine conventional transthoracic echocardiographic examination, LV myocardial 
systolic velocities were evaluated with pulsed wave tissue Doppler in the short and long axis 
with simultaneous electrocardiographic monitoring.
Results: Long axis first systolic velocity (SW1) of mild-moderate and severe MS was much 
lower than normal group (10.7 ± 2.3 in normal group vs. 7.9 ± 1.3 in mild-moderate MS 
group vs. 6.2 ± 1.4 in severe MS group, p < 0.001). Long axis Q-SW1 duration was longer 
in mild-moderate MS group (145 ± 32 in normal group vs. 199 ± 43 in mild-moderate MS 
group, p = 0.001). Short axis Q-SW2 duration was longer in normal group compared to mild-
-moderate and severe MS groups (298 ± 41 in normal group vs. 245 ± 37 in mild-moderate 
MS group vs. 234 ± 26 in severe MS group, p < 0.001). Significant correlation between mitral 
valve area and SW1, Q-SW1 was determined (p = 0.01).
Conclusions: Even if LV functions are normal with conventional 2D echocardiography, 
subclinical systolic dysfunction exists in MS. Also, there is a dyssynchrony between contraction 
of longitudinal and circumferential myofibrils. (Cardiol J 2014; 21, 1: 33–38)
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Introduction
Mitral stenosis (MS) is still the most common 
complication of acute rheumatic fever in Turkey. 
Carditis affects not only cardiac valves but also 
myocardium. Conventional echocardiographic 
methods give valuable information about valvular 
involvement and function but they are not enough 
for the evaluation of myocardial involvement. In 
previous studies the authors showed that patients 
with MS had significantly impaired long-axis fun-
ction evaluated by M-mode or tissue Doppler 
echocardiography despite normal global systolic 
function [1–3].
In this study, we aimed to evaluate the subcli-
nical left ventricular (LV) systolic dysfunction and 
contraction of short and long axial circumferential 
and longitudinal fibers by pulsed wave tissue 
Doppler in rheumatic MS patients who preserved 
LV systolic function in 2D echocardiography.
Methods
The characteristic of the study
Thirty-five patients who had moderate to se-
vere rheumatic MS hospitalized for mitral balloon 
valvuloplasty in Turkiye Yuksek Ihtisas Education 
and Research Hospital between September 2010 
and January 2011 were included as the study group. 
Fifteen patients who had normal echocardiogra phic 
findings and similar characteristics with study 
group were selected as the control group. All par-
ticipants were informed about the study and their 
consents were obtained.
Exclusion criteria
Exclusion criteria are given below:
 — atrial fibrillation, atrial flutter and other tachy-
-brady arrhytmias;
 — electrocardiographic bundle branch block;
 — preexcitation syndromes;
 — coronary artery disease;
 — non rheumatic valve disease;
 — moderate to severe valvular regurgitation.
Echocardiographic examination
All patients underwent transthoracic echo-
cardiographic examination by Vivid pro 7 (GE 
Horten, Norway) echocardiography device with 
a 1.5–3.6 MHz transducer. All echocardiographic 
examinations were performed by the same opera-
tor who was blinded for groups of the patients. LV 
systolic diameter (LVSD) and LV diastolic diameter 
(LVDD), left atrium diameters and mitral valve area 
(MVA) with pressure half time and planimetric 
methods were noted. LV ejection fraction (LVEF) 
with biplane area method from apical window and 
fractional shortening (FS) with M-mode echo-
cardiography according to the formula: FS (%) = 
= ([LVDD – LVSD] / LVDD × 100) were calculated.
LV myocardial systolic velocities were exa-
mined with pulsed wave tissue Doppler (PWTD) 
in the short and long axis with simultaneous elec-
trocardiographic (ECG) monitoring. Apical and 
parasternal windows were used for PWTD echo-
cardiography. To measure velocities along the short 
axis, the sample volume was positioned on the 
mid-portion of the middle region of the posterior LV 
wall on a parasternal long-axis view and velocities 
along the long axis were measured by putting the 
sample volume in the subendocardial portion of the 
middle region of the posterior LV wall on an apical 
long-axis view. Each PWTD measurement revealed 
two peak systolic velocities (SW1 — first systolic 
velocity peak; SW2 — second systolic velocity 
peak). Also, the durations from Q wave in ECG to 
SW1 and SW2 were noted respectively as Q-SW1 
and Q-SW2 (Fig. 1). The average of 3 cycles was 
calculated.
Statistical analysis
All data were evaluated by the SPSS (Statisti-
cal for Social Sciences for Windows, version 17.0). 
Parametric and nonparametric distribution of the 
variables was assessed by Kolmogorov-Smirnov 
test. Parametric data were expressed as mean 
± standard deviation and qualitative data as numbers 
and percentages. Pearson test was used for cor-
relation analysis of the parametric data. One-way 
ANOVA test was used for the comparison of the 
quantitative data between the groups. The results 
were considered statistically significant at the 
level of p < 0.05.
Results
Fifty patients included in the study were 
divided into 3 groups according to severity of 
MS as normal mitral valve, mild-moderate MS 
(MVA > 1.1 cm2) and severe MS (MVA £ 1.1 cm2).
Basal characteristics were similar between the 
groups (Table 1). There were no statistical differen-
ces in heart rate, systolic and diastolic blood pres-
sure, EF, FS, LVDD and LVSD between the groups. 
Left atrium diameter and systolic pulmonary artery 
pressure were not different between the groups 
evaluated with one-way ANOVA test (Table 2).
Long axis SW1 velocities of the mild-moderate 
and the severe MS were much lower than the nor-
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Figure 1. Pulsed wave tissue Doppler velocities of left ventricle posterior wall in the apical long axis view; SW1 — first 
systolic velocity peak and SW2 — second systolic velocity peak. Also, the duration from Q wave in ECG to SW1 and 
SW2 were noted respectively as Q-SW1 and Q-SW2. 
Table 1. Characteristic features of the patients.
Normal group  
(n = 15)
Mild-moderate MS  
(n = 20)
Severe MS  
(n = 15)
Age [year] 36 ± 8 44 ± 10 42 ± 10
Sex (female/male) 11/4 17/3 13/2
Heart rate [bpm] 77 ± 11 76 ± 13 78 ± 8
Systolic blood pressure [mm Hg] 112 ± 12 114 ± 16 106 ± 12
Diastolic blood pressure [mm Hg] 73 ± 7 71 ± 10 68 ± 9
Acetylsalicylic acid 0 16 (80%) 12 (80%)
Beta-blocker 1 (6.6%) 15 (75%) 11 (73%)
Diuretic 0 5 (25%) 12 (80%)
Calcium channel blocker 0 0 1 (6.6%)
Digoxin 0 1 (5%) 0
MS — mitral stenosis
Table 2. Echocardiographic findings.
Normal group  
(n = 15)
Mild-moderate MS  
(n = 20)
Severe MS  
(n = 15)
Mitral valve area [mm²] > 40 14 ± 1.7 10 ± 0.8
Mean mitral gradient [mm Hg] – 6.8 ± 3 10.8 ± 2.1
Interventricular septum [mm] 8.4 ± 0.7** 9.6 ± 0.9 9.4 ± 1.1
LVPW [mm] 8.6 ± 0.6 9.6 ± 0.94 9.0 ± 1.2
Left atrial diameter [mm] 33 ± 2* 44 ± 3 46 ± 5
LVDD [mm] 28 ± 3 29 ± 4 28 ± 3
LVSD [mm] 44 ± 2 46 ± 3 43 ± 10
Fractional shortening [%] 35 ± 3 35 ± 4 36 ± 4
Ejection fraction [%] 65 ± 3 65 ± 6 65 ± 5
SPAP [mm Hg] 23 ± 2#, & 36 ± 12$ 52 ± 13
*p < 0.001 compared to mild-moderate and severe MS; **p < 0.05 compared to mild-moderate and severe MS; #p < 0.01 compared to 
mild-moderate MS; &p < 0.001 compared to severe MS; $p< 0.001 compared to severe MS; MS — mitral stenosis; LVPW — left ventricular 
posterior wall; LVDD — left ventricular diastolic diameter; LVSD — left venticular systolic diameter; SPAP — systolic pulmonary artery pressure
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mal group (10.7 ± 2.3 in normal group vs. 7.9 ± 
± 1.3 in mild-moderate MS group vs. 6.2 ± 1.4 in 
severe MS group, p < 0.001). Long axis SW2 ve-
locities were found statistically different between 
mild-moderate and severe MS (6.0 ± 1.2 vs. 4.7 ± 
± 1.2, p < 0.01). Long axis Q-SW1 duration was 
longer in mild-moderate MS group (145 ± 32 in 
normal group vs. 199 ± 43 in mild-moderate MS 
group, p = 0.001). Short axis SW1, SW2 and Q-SW1 
mean values were not different between the groups 
but short axis Q-SW2 duration was longer in the 
normal group compared to the mild-moderate and 
the severe MS groups (298 ± 41 in normal group 
vs. 245 ± 37 in mild-moderate MS group vs. 
234 ± 26 in severe MS group, p < 0.001) (Table 3). 
Correlation between MVA and SW1, Q-SW1 was 
investigated with Pearson test. Significant corre-
lation between MVA and SW1, Q-SW1was deter-
mined (p = 0.01) (Table 4).
Discussion
Histological studies showed that LV myocar-
dium was composed of circumferential fiber in the 
middle portion, longitudinal fibers in subendocar-
dial and subepicardial portions [4, 5]. LV systolic 
function is accomplished by contraction of both 
fibers [6]. Longitudinal fibers contract earlier in 
early systole and LV takes a shape of a sphere 
during isovolumetric contraction phase [7–9]. Im-
mediately after this, circumferential fibers contract 
and LVEF is completed [10, 11].
In previous studies, contraction of circumfe-
rential and longitudinal fibers was investigated with 
conventional M-mode echocardiography [12]. With 
the help of new modalities, myocardial tissue ve-
locities could be noninvasively measured [13, 14]. 
It would be possible to get valuable information 
about LV short and long axial myocardial functions 
with tissue Doppler echocardiography [15–19].
It is generally assumed that LV functions are 
preserved in pure MS. However, varying degrees of 
LV systolic dysfunction were detected in previous 
studies [20, 21]. Many hemodynamic and myocar-
dial factors have been blamed for LV dysfunction 
in MS, such as reduction in LV filling, chronic 
myocardial inflammation, scarring of subvalvular 
apparatus, reduction of LV compliance and dia-
stolic dysfunction, increased afterload, abnormal 
right-left septal interaction, and pulmonary hyper-
tension [22]. It still remains a challenge whether 
LV systolic dysfunction is a result of functional or 
myocardial factors in patients with MS.
When we look at the earliest studies, in 1953, 
Grant [23] in his article suggested that part of the 
Table 3. Pulsed wave tissue Doppler recordings.
Normal group (n = 15) Mild-moderate MS (n = 20) Severe MS (n = 15)
Long axis
SW1 [cm/s] 10.7 ± 2.3* 7.9 ± 1.3 6.2 ± 1.4
SW2 [cm/s] 5.4 ± 0.7 6.0 ± 1.2** 4.7 ± 1.2
Q-SW1 [ms] 145 ± 32*** 199 ± 43 180 ± 46
Q-SW2 [ms] 259 ± 37 258 ± 43 258 ± 44
Short axis
SW1 [cm/s] 7.5 ± 1.2 7.1 ± 1.2 7.0 ± 1.4
SW2 [cm/s] 4.8 ± 1.0 5.5 ± 1.1 5.5 ± 1.3
Q-SW1 [ms] 182 ± 28 178 ± 38 168 ± 28
Q-SW2 [ms] 298 ± 41* 245 ± 37 234 ± 26
*p < 0.001 compared to mild-moderate and severe MS; **p < 0.01 compared to severe MS; ***p = 0.001 compared to mild-moderate MS; 
MS — mitral stenosis; SW1 — first systolic velocity peak; SW2 — second systolic velocity peak; Q-SW1 — the duration from Q wave to SW1; 
Q-SW2 — the duration from Q wave  to SW2
Table 4. The correlation between mitral valve 





SW1 long axis –0.431* 0.002
SW2 long axis 0.226 0.115
Q-SW1 long axis 0.483* 0.000
Q-SW2 long axis –0.008 0.955
SW1 short axis –0.116 0.423
SW2 short axis 0.228 0.111
Q-SW1 short axis –0.036 0.803
Q-SW2 short axis –0.471* 0.001
*Correlation significance p < 0.01 (2-tailed); SW1 — first systolic 
velocity peak; SW2 — second systolic velocity peak; Q-SW1 — the 
duration from Q wave to SW1; Q-SW2 — the duration from Q wave 
to SW2
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LV was atrophic in patients with MS. He found that 
the posterior wall of the LV in patients with MS was 
shortened and atrophic. These ventricular changes 
were explained to be due to partial immobilization 
of the ventricle by the fibrotic posterior mitral le-
aflet and also to the chronic ventricular inactivity 
resulting from long-standing reduced ventricular 
filling. In 1968, Feigenbaum et al. [24] showed that 
significant increase in LV end diastolic pressure 
occurred despite increase in MVA in patients with 
MS who had had mitral valvulotomy. 
The concept of ventricular atrophy would also 
explain this increase in LV end diastolic pressure 
because of abnormal compliance of the LV. We can 
also derive from these studies that chronic volume 
underload of the LV due to mitral valve stenosis 
over years and decades may be responsible for LV 
systolic dysfunction.
Lee et al. [25] demonstrated that MS patients 
with reduced global LV function usually had seg-
mental contraction abnormalities. In their study, 
they also showed that most of MS patients who had 
impaired EF gained improvement in LV function 
after mitral valvuloplasty, while some did not. They 
concluded that both myocardial and mechanical 
factors would be responsible for LV dysfunction 
in patients with MS [25].
Acute rheumatic carditis affects not only cardiac 
valves but also myocardial tissue. In our study, we 
evaluated the subclinical LV systolic dysfunction and 
contraction of short and long axial circumferential 
and longitudinal fibers by PWTD in rheumatic MS 
patients who preserved LV systolic function in 2D 
echocardiography. Contraction of longitudinal fibers 
in isovolumetric contraction phase is impaired in 
MS patients compared to normal healthy subjects as 
a result mean longitudinal axis SW1 velocity 
decrease and this decrease is correlated with the 
severity of MS (p < 0.001). Moreover, the time re-
quired for stimulation of longitudinal fibers increases 
and this increase is correlated with the severity of 
MS (p = 0.01). As a result, while LV functions are 
normal with conventional 2D echocardiography in 
MS, subclinical systolic dysfunction is present and 
there is also a dyssynchrony between circumferen-
tial and longitudinal myofibrils.
In their study, Ozdemir et al. [20] showed 
the myocardial velocities of the LV indicating LV 
function were found to be significantly lower in 
patients with pure MS. In the study performed by 
Ozer at al. [21] it was showed that patients with 
MS had significantly impaired long-axis function 
evaluated by M-mode or tissue Doppler echocar-
diography despite normal global systolic function.
In their study, Arat et al. [26] found that myo-
cardial S and E velocities and the E/A ratio were 
increased after percutaneous mitral valve balloon 
valvotomy with no significant change in the LVEF 
and the total ejection isovolume index which is 
more reflective of overall cardiac function than 
systolic or diastolic functions alone. They emp-
hasized that a subclinical LV dysfunction might 
be responsible for no significant change in LVEF.
Inflammation and edema due to acute rheu-
matic fever resulting in fusion, thickening and 
shortening of mitral and subvalvular apparatus 
also affects anatomical and contractile features of 
myofibrils [27–29]. In their ultrastructural study, 
Lee at al. [25] showed intense myofibril loss due 
to both myofibril degeneration and impaired mito-
chondria to myofibril ratio in pure rheumatic MS 
patients. As a result they specified that the main 
pathological mechanism responsible for LV function 
disturbance was myocardial involvement due to 
rheumatic process in rheumatic pure MS [30]. Colle 
et al. [31] revealed that rheumatic MS patients 
had anterior and posterior hypokinesia and mean 
shortening of hypokinetic segments was lower in 
MS patients than in normal individuals. They also 
showed that patients who had contractile abnor-
mality had lower EF and circumferential myofibril 
shortening velocity.
Conclusions
In our study, we showed that mild-moderate 
and severe MS patients had significantly lower 
myocardial systolic velocity which was a marker 
of quantitative contractile function than normal 
subjects despite the fact that they had similar EF 
values. We still do not exactly know that which 
factors are more important (myocardial, mechanical 
or both) in case of LV dysfunction in MS patients. 
However, we exactly know that LV functions are 
not preserved and at least a subclinical LV dysfun-
ction exists in pure MS.
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